Market Pulse50Neutral

Teladoc Health, Inc.Opportunity Rank #90(TDOC) Intrinsic Value & DCF Analysis (2026)

Sector: Healthcare

Current Price

$5.48

Last updated: Mar 24, 2026

Price vs Intrinsic Value

$5.48
Price
$57.64
Intrinsic Value
Undervalued by 952%MOS: $46.11

Fundamental Score

67/100
Bullish

Weighted across 6 signals

Narrative Score

53/100
Weak

No change vs previous

The intrinsic value of Teladoc Health, Inc. (TDOC) is estimated at $57.64 per share based on a 10-year discounted cash flow (DCF) analysis. At the current price of $5.48, the stock appears undervalued relative to its projected cash flow fundamentals. This estimate assumes a 14.43% long-term growth rate and a 10.00% discount rate (calculated: 6.98%), reflecting expected future free cash flow and cost of capital.

The intrinsic value of Teladoc Health, Inc. (TDOC) is estimated at $57.64 per share based on a 10-year discounted cash flow (DCF) analysis. At the current price of $5.48, the stock appears undervalued relative to its projected cash flow fundamentals. This estimate assumes a 14.43% long-term growth rate and a 10.00% discount rate (calculated: 6.98%), reflecting expected future free cash flow and cost of capital.

Valuation Details

$57.64
▲ 951.82% upside
20% margin of safety: $46.11
Years: 10Growth Rate: 14.43%
Want to create your own valuation? Create a free account.

Capital Efficiency

Average Quarterly ROIC
-2.03%
Cost of Capital (estimated)9%
Value StatusUnderperforming Capital

The company is earning below its required return. This may indicate inefficient use of capital or excess cash that isn't being reinvested.

Complete historical ROIC is available with
.

Fundamental Details

67/100
BullishWeighted across 6 signals
DCF Discount
951.8% discount to price
100
FCF Yield
36.9% trailing FCF yield
100
ROIC vs WACC
ROIC -2.0% vs WACC 9.0% (-0.2x)
0
Net Debt / FCF
0.6x net debt to FCF
88
Buybacks
Share count growing
30
FCF CAGR (5Y)
229.7% 5Y FCF CAGR (adjusted)
100
Strengths: DCF Discount, FCF Yield. Concerns: ROIC vs WACC, Buybacks.

Narrative Details

53/100
Weak
Vs 6-Month Baseline:Average (52nd pct)Weighted across 3 recent drivers
Trend: StableConfidence: 85%Updated: 1h ago
Sources: 42 (29 News · 13 Analyst)
Drivers(last 30 days)
29 news sentiment+0.2
Analyst upgrades+0.1
12 analyst reiterations0.0

Investment Coach

Updated 14h ago
BUYConfidence: 54%
Thesis
Teladoc Health, Inc. presents a compelling investment opportunity with an estimated fair value nearly 993% above its current price and strong free cash flow yield of 36.9%, supported by constructive fundamentals. Despite trailing returns relative to its cost of capital, the company's significant free cash flow growth and bullish fundamental score suggest potential for substantial upside.
Key Risk
The key risk lies in the company's negative ROIC versus WACC spread, indicating returns are currently below the cost of capital, which could hinder long-term value creation.
Signals To Watch
  • Monitor whether valuation discount remains above 10%.
  • Track ROIC vs WACC spread for sustained improvement.
  • Follow narrative trend for meaningful shifts in the score direction.
Ask the Coach - Available with
Historical Growth Rates
Free Cash Flow- - -Trend CAGR: 14.61%5 Year CAGR: 12.26%

Free Cash Flow (in millions)

TTM2025202420232022202120202019201820172016201520142013
$361$303$304$506$206$203-$27$41$4-$29-$48-$39-$10-$5

How Intrinziq Estimates Fair Value

Intrinziq estimates Teladoc Health, Inc.'s intrinsic value using a discounted cash flow (DCF) model based on free cash flow trends and a market-based discount rate. The model projects future cash flows over ten years and discounts them using a market return assumption to estimate fair value.

Teladoc Health, Inc.Healthcare

Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.